Designing a Virtual Reality Intervention to Improve Physical and Psychological Health in Intensive Care Units (GAMERS)

February 17, 2026 updated by: Duke University
The goal of this study is to explore if Virtual Reality helps patients in the cardiothoracic ICU move more and feel better. Participants will be asked to answer a survey about anxiety, depression, and loneliness. The study team will teach participants how to use the VR device and how to play the game. Participants will play the game at least once per day, but can play as much as they want. Study activities include nurse facilitated patient use of VR applications that involve upper body movement (e.g., using arms and hands to dance or hit objects in a virtual reality environment).

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

Patients who survive critical illness and prolonged intensive care unit (ICU) stays are at risk for debilitating physical (deconditioning, skin injury, and infection), and mental health impairment (depression, anxiety and PTSD). Early mobility improves these deleterious outcomes but is challenging to implement in patients on prolonged bedrest. The purpose of this study is to compare a nurse-led implementation of a Virtual Reality (VR) experience in the Cardio-Thoracic Intensive Care Unit (CT-ICU) to standard of care to improve mobility for patients on prolonged bedrest. The investigators hypothesize that nurse-led implementation of VR experiences in the CT-ICU, in combination with engineering-led patient-centered customization of the VR applications, will improve both the physical and psychological function of ICU patients on prolonged bedrest.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult
  • English speaking
  • 3+ days ICU admission with limited mobility

Exclusion Criteria:

  • Pregnancy
  • Blind/severe visual impairment
  • History of seizures
  • Intubation/sedation
  • Special enteric contact isolation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Virtual Reality (VR) intervention
Cohort for observing the effects of the VR intervention on ICU mobility.
Commercially-based VR experience used to help move upper extremities to music, similar to dancing or Tai-Chi.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility as measured by nursing time required
Time Frame: up to 6 months
For each participant, the total nursing time spent (in minutes) setting up and delivering the intervention will be recorded.
up to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Usability as measured by patient-reported ease of playing the game
Time Frame: up to 6 months
Usability: Using a 5-point Likert scale (0- very difficult to 5- very easy; higher is better outcome), participants will be surveyed after the intervention period to assess ease of playing the game.
up to 6 months
Usability as measured by patient-reported ease of hand controller use
Time Frame: up to 6 months
Usability: Using a 5-point Likert scale (0- very difficult to 5- very easy; higher is better outcome), participants will be surveyed after the intervention period to assess ease of hand controller use.
up to 6 months
Usability as measured by patient-reported wearability of headset
Time Frame: up to 6 months
Usability: Using a 5-point Likert scale (0- very difficult to 5- very easy; higher is better outcome), participants will be surveyed after the intervention period to assess wearability of headset.
up to 6 months
Usability as measured by patient-reported comfort of headset
Time Frame: up to 6 months
Usability: Using a 5-point Likert scale (0- very difficult to 5- very easy; higher is better outcome), participants will be surveyed after the intervention period to assess comfort of headset.
up to 6 months
Number of participants who find the intervention acceptable
Time Frame: up to 6 months
Acceptability: Participants will be asked if they would recommend this game to a friend or loved one, yes or no.
up to 6 months
Change in mobility activity frequency
Time Frame: Baseline, 6 months
To determine if a VR intervention increases mobility for patients on prolonged bedrest, the frequency of VR sessions is recorded. Frequency will be reported as counts.
Baseline, 6 months
Change in mobility activity time
Time Frame: Baseline, 6 months
To determine if a VR intervention increases mobility for patients on prolonged bedrest, the duration of each VR session is recorded. Activity will be reported as total minutes.
Baseline, 6 months
Change in Hospital Anxiety and Depression Scale (HADS) - anxiety
Time Frame: Baseline to day 10 or ICU transfer, whichever comes first
The Hospital Anxiety and Depression Scale (HADS) is a self-report scale used to measure the severity of depression and anxiety in patients with comorbid medical conditions. The total score for anxiety ranges from 0 to 21, where a higher score indicates greater anxiety.
Baseline to day 10 or ICU transfer, whichever comes first
Change in Hospital Anxiety and Depression Scale (HADS) - depression
Time Frame: Baseline to day 10 or ICU transfer, whichever comes first
The Hospital Anxiety and Depression Scale (HADS) is a self-report scale used to measure the severity of depression and anxiety in patients with comorbid medical conditions. The total score for depression ranges from 0 to 21, where a lower score indicates greater depression.
Baseline to day 10 or ICU transfer, whichever comes first
Change in UCLA 3-item Loneliness Scale
Time Frame: Baseline to day 10 or ICU transfer, whichever comes first
This scale comprises 3 questions that measure three dimensions of loneliness: relational connectedness, social connectedness and self-perceived isolation. The total score ranges from 0 to 9, where a higher score indicates greater loneliness.
Baseline to day 10 or ICU transfer, whichever comes first

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in BDNF (brain-derived neurotrophic factor) level
Time Frame: Baseline to day 10 or ICU transfer, whichever comes first
BDNF may play a role in the biology of mood disorders.
Baseline to day 10 or ICU transfer, whichever comes first
Change in TNF (tumor necrosis factor) level
Time Frame: Baseline to day 10 or ICU transfer, whichever comes first
TNF is a protein that plays a role in the development of depression and other psychiatric disorders.
Baseline to day 10 or ICU transfer, whichever comes first

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Anna E Mall, MSN, Duke University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 4, 2024

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2026

Study Registration Dates

First Submitted

December 9, 2024

First Submitted That Met QC Criteria

January 27, 2025

First Posted (Actual)

January 29, 2025

Study Record Updates

Last Update Posted (Actual)

February 18, 2026

Last Update Submitted That Met QC Criteria

February 17, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • PRO00116448

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mobility

Clinical Trials on VR assisted mobility

Subscribe